{"name":"Lilly Asian Ventures","permalink":"lilly-asian-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/lilly-asian-ventures","homepage_url":"http://www.lillyasianventures.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"86-13817920748","description":"","email_address":"lilly_asian_ventures@lilly.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jun 24 07:03:30 UTC 2009","updated_at":"Wed Jun 24 07:14:04 UTC 2009","overview":"<p>Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Their initial focus will be primarily on opportunities in China, although they will consider investment opportunities elsewhere in east and south Asia.</p>","image":{"available_sizes":[[[150,79],"assets/images/resized/0005/0452/50452v1-max-150x150.png"],[[184,98],"assets/images/resized/0005/0452/50452v1-max-250x250.png"],[[184,98],"assets/images/resized/0005/0452/50452v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"21 F, 1 Corporate Avenue","address2":"No. 222, Hu Bin Road","zip_code":"200021","city":"Shanghai","state_code":null,"country_code":"CHN","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"Senior Managing Director","person":{"first_name":"Darren","last_name":"Carroll","permalink":"darren-carroll","image":{"available_sizes":[[[119,150],"assets/images/resized/0005/0453/50453v1-max-150x150.png"],[[150,188],"assets/images/resized/0005/0453/50453v1-max-250x250.png"],[[150,188],"assets/images/resized/0005/0453/50453v1-max-450x450.png"]],"attribution":""}}},{"is_past":false,"title":"Managing Director ","person":{"first_name":"Yi","last_name":"Shi","permalink":"yi-shi-2","image":{"available_sizes":[[[110,138],"assets/images/resized/0005/0454/50454v1-max-150x150.jpg"],[[110,138],"assets/images/resized/0005/0454/50454v1-max-250x250.jpg"],[[110,138],"assets/images/resized/0005/0454/50454v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://equityhelpdesk.com/node/3920","source_description":"HD Biosciences Raises First Round","raised_amount":null,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":8,"company":{"name":"HD Biosciences","permalink":"hd-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0005/0450/50450v1-max-150x150.jpg"],[[250,106],"assets/images/resized/0005/0450/50450v1-max-250x250.jpg"],[[298,127],"assets/images/resized/0005/0450/50450v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercepharmamanufacturing.com/press-releases/innovent-biologics-adds-25-million-expand-its-antibody-pipeline-and-its-man","source_description":"Innovent Biologics Adds $25 Million to Expand its Antibody Pipeline and its Manufacturing Capabilities","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":16,"company":{"name":"Innovent Biologics","permalink":"innovent-biologics","image":{"available_sizes":[[[150,41],"assets/images/resized/0022/1443/221443v1-max-150x150.jpg"],[[250,69],"assets/images/resized/0022/1443/221443v1-max-250x250.jpg"],[[302,84],"assets/images/resized/0022/1443/221443v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}